Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar A Jammah, Fahad Alqahtani, Metib Alotaibi, Raed Aldahash, Amani M Alhozali, Fahad Alsabaan, Mohammed Almehthel, Naser Aljuhani, Ali Aldabeis, Moneer Alamri, Waleed Maghawry, Naweed Alzaman, Alshaima Alshaikh, Omar M Alnozha, Emad R Issak, Saud Alsifri
INTRODUCTION: This study aimed to assess the safety and effectiveness of semaglutide, administered either by weekly subcutaneous (SC) injection or orally, in real-life practice in Saudi Arabia in individuals with type 2 diabetes mellitus (T2DM). METHODS: A retrospective chart review study was conducted at 18 Saudi Arabia centers. An accredited centralized institutional review board approved the study. Medical records were included for individuals of any age ≥ 18 years with uncontrolled T2DM...
December 19, 2023: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders